Drug Type Antibody oligonucleotide conjugates |
Synonyms- |
Target |
Action inhibitors, antagonists |
Mechanism GYS1 gene inhibitors, TfR1 antagonists(Transferrin receptor protein 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glycogen Storage Disease Type II | Preclinical | - | - |






